Literature DB >> 1720318

Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?

L A Manson1.   

Abstract

It is not clear how immunogenic tumours can grow from small inocula in syngeneic hosts that mount both T-cell and B-cell responses. In this article Lionel Manson argues that antibody coats the tumour cells, protecting them from attack by cytotoxic lymphocytes, and thus permits the tumour to continue to grow and overwhelm the host. These observations may explain the paradox that an immunogenic tumour overwhelms the tumour-bearing host in the face of an ongoing anti-tumour immune response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720318     DOI: 10.1016/0167-5699(91)90065-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  5 in total

Review 1.  A systematic review of humoral immune responses against tumor antigens.

Authors:  Miriam Reuschenbach; Magnus von Knebel Doeberitz; Nicolas Wentzensen
Journal:  Cancer Immunol Immunother       Date:  2009-06-28       Impact factor: 6.968

2.  Tumor cells express FcgammaRI which contributes to tumor cell growth and a metastatic phenotype.

Authors:  M B Nelson; J K Nyhus; K I Oravecz-Wilson; E Barbera-Guillem
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

3.  Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.

Authors:  C J Punt; J A Barbuto; H Zhang; W J Grimes; K D Hatch; E M Hersh
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

4.  Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.

Authors:  Deirdre R Ducken; Wendy C Brown; Debra C Alperin; Kelly A Brayton; Kathryn E Reif; Joshua E Turse; Guy H Palmer; Susan M Noh
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

5.  Paradoxical enhancement of tumor growth in mice with severe combined immunodeficiency which produce a human immunoglobulin G reactive against tumor cells.

Authors:  T Furukawa; M Watanabe; T Kubota; M Kitajima
Journal:  Jpn J Cancer Res       Date:  1994-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.